Lykkedegn Sine, Sorensen Grith Lykke, Beck-Nielsen Signe Sparre, Christesen Henrik Thybo
Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark; Clinical Institute, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark;
Institute of Molecular Medicine, Department of Cardiovascular and Renal Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Am J Physiol Lung Cell Mol Physiol. 2015 Apr 1;308(7):L587-602. doi: 10.1152/ajplung.00117.2014. Epub 2015 Jan 16.
Respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) are major complications to preterm birth. Hypovitaminosis D is prevalent in pregnancy. We systematically reviewed the evidence of the impact of vitamin D on lung development, surfactant synthesis, RDS, and BPD searching PubMed, Embase, and Cochrane databases with the terms vitamin D AND (surfactant OR lung maturation OR lung development OR respiratory distress syndrome OR fetal lung OR prematurity OR bronchopulmonary dysplasia). Three human studies, ten animal studies, two laboratory studies, and one combined animal and laboratory study were included. Human evidence was sparse, allowing no conclusions. BPD was not associated with vitamin D receptor polymorphism in a fully adjusted analysis. Animal and laboratory studies showed substantial positive effects of vitamin D on the alveolar type II cell, fibroblast proliferation, surfactant synthesis, and alveolarization. These data support the hypothesis of hypovitaminosis D as a frequent, modifiable risk factor of RDS and BPD, which should be tested in randomized controlled trials on pregnant women, those with threatening preterm delivery, or in the preterm neonates. Future experimental and human studies should aim to identify optimal time windows, vitamin D doses, and cut-off levels for 25-hydroxyvitamin D in interventions against RDS, BPD, and later adverse respiratory outcomes.
呼吸窘迫综合征(RDS)和支气管肺发育不良(BPD)是早产的主要并发症。孕期维生素D缺乏症很普遍。我们通过在PubMed、Embase和Cochrane数据库中检索“维生素D AND(表面活性剂或肺成熟或肺发育或呼吸窘迫综合征或胎儿肺或早产或支气管肺发育不良)”,系统回顾了维生素D对肺发育、表面活性剂合成、RDS和BPD影响的证据。纳入了三项人体研究、十项动物研究、两项实验室研究以及一项动物与实验室联合研究。人体证据稀少,无法得出结论。在一项全面调整分析中,BPD与维生素D受体多态性无关。动物和实验室研究表明,维生素D对II型肺泡细胞、成纤维细胞增殖、表面活性剂合成和肺泡化有显著的积极作用。这些数据支持维生素D缺乏症是RDS和BPD常见的、可改变的风险因素这一假设,应在针对孕妇、有早产风险的人群或早产新生儿的随机对照试验中进行验证。未来的实验和人体研究应旨在确定针对RDS、BPD及后续不良呼吸结局干预措施中的最佳时间窗、维生素D剂量以及25-羟基维生素D的临界水平。